| Sign In to gain access to subscriptions and/or personal tools. |
DOI: 10.1177/026765919801300608 © 1998 SAGE Publications Acute phase and opsonin response in cardiac surgery patients: influence of underlying cardiac diseaseDepartment of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen
Department of Cardiovascular Surgery, Justus-Liebig-University Giessen, Giessen
Department of Anaesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen Cardiopulmonary bypass (CPB) leads to an activation of plasma cascade systems, complement activation, and an acute phase response. To evaluate the influence of the underlying cardiac disease on the activation pattern of these systems, we compared inflammatory changes in coronary artery bypass grafting (CABG) patients with patients undergoing aortic valve replacement.
We investigated changes of the acute phase proteins
Concentrations of C3c and C4 decreased in both groups after the onset of CPB and C4 concentration remained below post-induction levels up to 24 h after onset of CPB (p = 0.04). Fibronectin levels dropped immediately before the onset of CPB (p = 0.01), reaching the lowest values after 20 min of extracorporeal circulation. Fibrinogen and It can be concluded that, based on pre-existing differences of acute phase protein concentrations, the CPB-induced inflammatory response takes place at a higher level in CABG patients. A different level in acute phase and opsonin response in patients suffering from coronary artery sclerosis may contribute to infectious complications in the postoperative period.
This article has been cited by other articles:
|
||||||||||||
1-proteinase inhibitor and fibrinogen, the unspecific opsonin fibronectin, and the complement components C3c and C4 induced by extracorporeal circulation in 12 patients undergoing aortic valve replacement and in 12 patients undergoing CABG. 